Open in Screener

PFE

Pfizer Inc

Sep 17 • 04:00PM ET

24.05

+0.15 0.63 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Index	S&P 500	P/E	12.79	EPS (ttm)	1.88	Insider Own	0.12%	Shs Outstand	5.68B	Perf Week	-2.12%
Market Cap	136.74B	Forward P/E	7.62	EPS next Y	3.16	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-4.07%
Enterprise Value	185.60B	PEG	106.61	EPS next Q	0.72	Inst Own	66.93%	Short Float	1.82%	Perf Quarter	0.21%
Income	10.73B	P/S	2.14	EPS this Y	-0.47%	Inst Trans	-0.69%	Short Ratio	2.47	Perf Half Y	-8.59%
Sales	63.83B	P/B	1.54	EPS next Y	1.94%	ROA	5.08%	Short Interest	103.47M	Perf YTD	-9.35%
Book/sh	15.60	P/C	10.32	EPS next 5Y	0.12%	ROE	12.16%	52W High	30.43 -20.97%	Perf Year	-17.83%
Cash/sh	2.33	P/FCF	10.99	EPS past 3/5Y	-28.69% -13.27%	ROIC	7.34%	52W Low	20.92 14.99%	Perf 3Y	-49.64%
Dividend Est.	1.71 (7.09%)	EV/EBITDA	7.23	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	67.34%	Volatility	2.17% 1.79%	Perf 5Y	-28.81%
Dividend TTM	1.71 (7.11%)	EV/Sales	2.91	EPS Y/Y TTM	510.84%	Oper. Margin	29.60%	ATR (14)	0.46	Perf 10Y	-20.60%
Dividend Ex-Date	Jul 25, 2025	Quick Ratio	0.85	Sales Y/Y TTM	14.72%	Profit Margin	16.81%	RSI (14)	42.50	Recom	2.50
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.16	EPS Q/Q	11938.10%	SMA20	-2.86%	Beta	0.50	Target Price	28.50
Payout	120.11%	Debt/Eq	0.70	Sales Q/Q	10.31%	SMA50	-2.70%	Rel Volume	1.10	Prev Close	23.90
Employees	81000	LT Debt/Eq	0.65	Earnings	Aug 05 BMO	SMA200	-3.33%	Avg Volume	41.85M	Price	24.05
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	34.39% 8.06%	Trades		Volume	46,095,295	Change	0.63%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Sep-17-25 10:04AM	MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response (Zacks)
05:45AM	5 Best High-Yield Dividend Stocks to Buy Now (Motley Fool)
Sep-16-25 02:58PM	Guggenheim Remains Bullish on Pfizer (PFE) (Insider Monkey)
11:19AM	MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer (Zacks)
11:15AM	Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon? (Zacks)
09:26AM	Loading…
09:26AM	Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)'s 2025-2026 COVID-19 Vaccine (Insider Monkey)
04:40AM	3 Things You Need to Know If You Buy Pfizer Today (Motley Fool)
04:22AM	3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever (Motley Fool)
Sep-15-25 01:07PM	CDC vaccine panel to meet this week: Here's what's at stake (CNBC TV)
10:27AM	CorMedix Rallies 60% YTD: Is This an Indication to Buy the Stock? (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:56AM	COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths (Zacks)
06:55AM	How Bad Is This Sector's Health Scare? (The Wall Street Journal)
Sep-13-25 01:56PM	Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths (FastCompany)
04:00AM	1 Reason Every Investor Should Know About Pfizer (PFE) Stock (Motley Fool)
08:14PM	Loading…
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
07:55PM	Review & Preview: Waiting for the Rate Cut (Barrons.com)
07:43PM	Drugmakers Fall on Report US to Claim Covid Shot Killed Kids (Bloomberg)
04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
04:00PM	Why Pfizer (PFE) Shares Are Sliding Today (StockStory)
02:56PM	Vaccine Stocks Fall on Reports FDA Will Allege Link Between Covid-19 Shots and Child Deaths (Barrons.com)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
01:37PM	COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says (MarketWatch)
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
12:11PM	Trump officials to link child deaths to COVID shots, Washington Post reports (Reuters)
11:35AM	Stock Market Today: Investors await opening trade from Gemini, Via, and Legence (TheStreet)
10:38AM	OLMA Stock Soars 47% in September So Far on Second PFE Deal (Zacks)
10:25AM	Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects (Zacks)
09:08AM	BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? (Zacks)
03:00AM	Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl (Barrons.com)
05:45PM	Loading…
Sep-11-25 05:45PM	Why Pfizer (PFE) Outpaced the Stock Market Today (Zacks)
12:49PM	Pfizer (PFE) and BioNTech SE Announce Positive Topline Results From an Ongoing Phase 3 Clinical Trial (Insider Monkey)
11:20AM	Pfizer (PFE), Astellas Post Favorable Trial Results for Bladder Cancer Combo (Insider Monkey)
09:52AM	Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? (Zacks)
04:25AM	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer (Zacks)
Sep-10-25 03:55PM	China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order (Investor's Business Daily)
12:12PM	Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales. (Barrons.com)
11:08AM	5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds (Zacks)
11:02AM	J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum (Zacks)
05:17AM	Pfizer-Olema Collaboration Targets Metastatic Breast Cancer (Insider Monkey)
Sep-09-25 08:00PM	Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women (The Wall Street Journal)
06:48PM	A Lyme Disease Vaccines Final Test Results Could Appear By Yearend. (Barrons.com)
11:21AM	Will LLY's Oncology Portfolio Provide Key Diversification Benefits? (Zacks)
08:50AM	Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds? (Zacks)
06:37AM	Crypto Stock Market Gambles Are Paying Off. Why That Luck Won't Last. (Barrons.com)
Sep-08-25 01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
10:15AM	Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth? (Zacks)
09:42AM	Investing in Oncology: 3 Cancer Stocks With Promising Pipelines (Zacks)
09:15AM	J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned? (Zacks)
06:45AM	Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula (Business Wire)
Sep-07-25 10:23AM	Pfizer Inc (PFE) Announces New Trial Collaboration With Olema Pharmaceuticals (Insider Monkey)
09:30AM	Is Pfizer a Millionaire Maker? (Motley Fool)
Sep-05-25 12:22PM	Analyst Report: BioNTech SE (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
Sep-04-25 03:00PM	Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity? (Zacks)
07:53AM	2 Top Dividend Stocks to Buy With Less Than $50 (Motley Fool)
06:45AM	3 Things You Need to Know if You Buy Pfizer Today (Motley Fool)
Sep-03-25 11:19AM	Pfizer defends Covid-19 vaccine effectiveness after Trump remarks (CNBC TV)
10:58AM	Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize (Bloomberg)
10:04AM	J&J Gears Up for Some Key New Drug Approvals and Launches (Zacks)
Sep-02-25 04:25PM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
10:18AM	Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path? (Zacks)
09:07AM	Is Pfizer Stock Underperforming the Nasdaq? (Barchart)
04:00AM	How AI advances will shape the drugmaker of the future (Pharma Voice)
03:28AM	Pfizer Inc. (PFE)'s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide (Insider Monkey)
03:21AM	3 High-Yield Dividend Stocks You Can Buy in September and Hold Forever (Motley Fool)
Sep-01-25 11:59AM	Pfizer's Golden Cross Signals Strength: How to Play the Stock (Zacks)
06:00AM	Pfizer's 7% Dividend: Income Gem or Value Trap? (Motley Fool)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
06:45AM	3 No-Brainer Stocks to Buy Right Now (Motley Fool)
12:10AM	Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine (Insider Monkey)
Aug-30-25 08:45AM	4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer (Motley Fool)
05:45AM	Better High-Yielding Dividend Stock: Realty Income vs. Pfizer (Motley Fool)
Aug-29-25 11:51AM	Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Aug-28-25 05:07PM	Inside the Trump Administrations Vaccine Politics (The Wall Street Journal)
12:04PM	FDA Approves Updated COVID-19 Vaccines but With Restrictions (Zacks)
11:13AM	MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate (Zacks)
10:10AM	Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum? (Zacks)
09:22AM	Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds? (Zacks)
07:55AM	FDA approves mRNA vaccines for new Covid-19 season amid political tension (Pharmaceutical Technology)
03:49AM	Analyst Report: Pfizer Inc. (Morningstar Research)
12:47AM	Morgan Stanley Lifts Pfizer (PFE) Price Target, Keeps Equalweight Rating (Insider Monkey)
Aug-27-25 11:35PM	Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q2 (StockStory)
02:30PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
01:56PM	FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use (Barrons.com)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
01:30PM	Unusual Put Option Activity in Pfizer Stock - Have Investors Turned Bearish? (Barchart)
12:50PM	Pfizer and BioNTechs COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 (Business Wire)
10:05AM	Will Camzyos Strengthen BMY's Cardiovascular Portfolio? (Zacks)
09:45AM	My 3 Favorite Stocks to Buy Right Now (Motley Fool)
08:08AM	LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors? (Zacks)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
09:40AM	GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU (Zacks)
Aug-25-25 10:41PM	Asian shares decline following Wall Street's dip (Associated Press Finance)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
01:22AM	Stocks slip on Wall Street after last week's rally (Associated Press Finance)
Aug-23-25 06:45AM	3 Unstoppable Dividend Stocks to Buy Right Now (Motley Fool)
Aug-22-25 04:27PM	Top Analyst Reports for NVIDIA, Cisco & Linde (Zacks)
09:39AM	AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM

Open in Screener

KMX

Carmax Inc

Sep 17 • 04:00PM ET

59.13

-1.22 -2.02 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: VTI VOO VB RSP VBR SPY IVV XLY IWR EQTY

Index	S&P 500	P/E	16.35	EPS (ttm)	3.62	Insider Own	0.51%	Shs Outstand	150.58M	Perf Week	-0.10%
Market Cap	8.87B	Forward P/E	13.31	EPS next Y	4.44	Insider Trans	-0.03%	Shs Float	149.31M	Perf Month	1.16%
Enterprise Value	27.51B	PEG	-	EPS next Q	1.04	Inst Own	107.43%	Short Float	9.94%	Perf Quarter	-8.23%
Income	558.50M	P/S	0.33	EPS this Y	21.43%	Inst Trans	-1.37%	Short Ratio	4.71	Perf Half Y	-15.92%
Sales	26.79B	P/B	1.42	EPS next Y	13.93%	ROA	2.04%	Short Interest	14.84M	Perf YTD	-27.68%
Book/sh	41.75	P/C	10.48	EPS next 5Y	-	ROE	8.97%	52W High	91.25 -35.20%	Perf Year	-24.94%
Cash/sh	5.64	P/FCF	16.41	EPS past 3/5Y	-22.80% -9.64%	ROIC	2.24%	52W Low	54.53 8.44%	Perf 3Y	-35.08%
Dividend Est.	-	EV/EBITDA	117.52	Sales past 3/5Y	-6.17% 5.34%	Gross Margin	10.17%	Volatility	3.37% 3.12%	Perf 5Y	-42.29%
Dividend TTM	-	EV/Sales	1.03	EPS Y/Y TTM	42.14%	Oper. Margin	-0.27%	ATR (14)	1.88	Perf 10Y	-0.76%
Dividend Ex-Date	-	Quick Ratio	0.80	Sales Y/Y TTM	3.17%	Profit Margin	2.08%	RSI (14)	46.08	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.39	EPS Q/Q	42.62%	SMA20	-1.88%	Beta	1.32	Target Price	76.50
Payout	0.00%	Debt/Eq	3.10	Sales Q/Q	6.09%	SMA50	-1.45%	Rel Volume	0.84	Prev Close	60.35
Employees	30048	LT Debt/Eq	2.97	Earnings	Sep 25 BMO	SMA200	-17.15%	Avg Volume	3.15M	Price	59.13
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	18.84% 0.56%	Trades		Volume	2,650,540	Change	-2.02%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99
Mar-19-24	Initiated	Mizuho	Neutral	$80
Sep-25-23	Upgrade	Wedbush	Neutral → Outperform	$85 → $90
Jun-12-23	Downgrade	Northcoast	Buy → Neutral
Feb-23-23	Resumed	Truist	Hold	$66
Jan-11-23	Downgrade	JP Morgan	Neutral → Underweight	$60
Jan-05-23	Downgrade	Argus	Buy → Hold
Dec-23-22	Reiterated	Oppenheimer	Outperform	$100 → $75
Oct-03-22	Downgrade	Stephens	Overweight → Equal-Weight	$105 → $64
Sep-09-22	Downgrade	BofA Securities	Neutral → Underperform	$146 → $100
May-02-22	Initiated	Needham	Hold
Apr-13-22	Downgrade	JP Morgan	Overweight → Neutral	$130 → $110
Apr-06-22	Downgrade	BofA Securities	Buy → Neutral	$195 → $165

Show Previous Ratings

Sep-09-25 11:32PM	Q2 Rundown: CarMax (NYSE:KMX) Vs Other Vehicle Retailer Stocks (StockStory)
05:20PM	Lands' End (LE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Sep-04-25 05:00PM	CarMax Announces Second Quarter Conference Call (Business Wire)
01:14PM	CarMax (KMX) Launches New Brand Positioning, Introduces New "Wanna Drive?" Tagline (Insider Monkey)
08:40AM	America's Car-Mart (CRMT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
12:34AM	Loading…
Sep-02-25 12:34AM	1 S&P 500 Stock to Target This Week and 2 That Underwhelm (StockStory)
Aug-28-25 08:10AM	Dick's Sporting Goods (DKS) Tops Q2 Earnings and Revenue Estimates (Zacks)
03:55AM	What Are Hertz and Amazon Up to Right Now? (Motley Fool)
Aug-26-25 01:30PM	Understanding electric vehicle financing and loans (Stacker)
Aug-25-25 08:05AM	CarMax is Shaping the Future of Car Shopping with New "Wanna Drive?" Brand Positioning and Tagline (GlobeNewswire)
06:30AM	CarMax ditches longtime tagline, repositions brand around omnichannel (Marketing Dive)
Aug-21-25 03:45PM	3 Stocks Down Over 30% That Look Like Buys (Motley Fool)
09:28AM	Can Carvana's Same-Day Delivery Fuel Profits and Market Share? (Zacks)
08:15AM	Carvana CEO Offloads Shares: Should Investors Reassess CVNA Stock? (Zacks)
Aug-20-25 01:03PM	Carvana's stock is falling, and Amazon is to blame (MarketWatch)
08:13AM	Loading…
08:13AM	Hertz partners with Amazon Autos to sell used vehicles online (Reuters)
Aug-18-25 10:19AM	Are Wall Street Analysts Predicting CarMax Stock Will Climb or Sink? (Barchart)
Aug-15-25 02:03PM	Final Trades: Uber, IBM, Alexandria Real Estate and Carmax (CNBC TV)
12:01AM	Reasons to Avoid KMX and 1 Stock to Buy Instead (StockStory)
Aug-12-25 10:02AM	1 Small-Cap Stock to Consider Right Now and 2 Facing Challenges (StockStory)
Aug-10-25 05:57AM	Street Calls of the Week (Investing.com)
Aug-08-25 07:57AM	CarMax (KMX) Fell Amid Concerns Over Sustaining Growth Rates (Insider Monkey)
Aug-06-25 02:50PM	Why CarMax (KMX) Stock Is Up Today (StockStory)
02:14PM	Emerson Electric slips, Carmax upgraded, Perrigo sales miss (Yahoo Finance Video)
Aug-04-25 11:11AM	How ADESA Is Supercharging Carvana's Next Phase of Growth (Zacks)
Aug-01-25 04:23PM	Carvanas 10,000% Rally From Low Deals $7 Billion Blow to Shorts (Bloomberg)
Jul-31-25 11:17AM	Is CVNA Stock a Buy Now After Record-Breaking Q2 Results? (Zacks)
Jul-29-25 10:15AM	What to Expect From CarMax's Q2 2026 Earnings Report (Barchart)
Jul-28-25 11:45AM	Repairify Expands Sales Leadership Team, Announces Hiring of New Vice President of Sales, Additional Sales Team Promotions (Business Wire)
Jul-25-25 08:58AM	Carvana Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock? (Zacks)
08:08AM	Loading…
Jul-21-25 08:08AM	CarMax (KMX) Traded Lower Amid Macro Uncertainty (Insider Monkey)
Jul-18-25 11:48AM	The Used-Car Market Is Ramping Up. Are Carvana and CarMax Stock Along for the Ride? (Barrons.com)
Jul-17-25 12:32AM	3 of Wall Street's Favorite Stocks with Questionable Fundamentals (StockStory)
Jul-15-25 12:38AM	2 Profitable Stocks to Target This Week and 1 to Think Twice About (StockStory)
Jul-11-25 09:04AM	Alphyn Capital Management Exited CarMax (KMX) as Share Price Stagnated (Insider Monkey)
Jul-10-25 01:58PM	CarMax, Inc. (KMX): A Bull Case Theory (Insider Monkey)
Jul-07-25 04:19PM	3 retail stock picks as Trump's trade deadline looms (Yahoo Finance Video)
10:12AM	5 Insightful Analyst Questions From CarMax's Q2 Earnings Call (StockStory)
09:37AM	Does Carvana's High Price-to-Sales Multiple Still Make Sense? (Zacks)
Jul-04-25 03:32AM	RBC Maintains Outperform on CarMax, Raises Price Target After Strong Results (Insider Monkey)
Jul-03-25 01:00AM	It's July Fourth. Are You Ready for Yet Another American Revolution? (Barrons.com)
Jun-30-25 04:10PM	IBD Stock Of The Day Offers A Buy Opportunity Amid 120% Run Since April (Investor's Business Daily)
Jun-27-25 03:27PM	Analyst Report: CarMax, Inc. (Morningstar Research)
12:40AM	1 Safe-and-Steady Stock with Impressive Fundamentals and 2 to Turn Down (StockStory)
Jun-25-25 11:03AM	CarMax Stock: Is KMX Underperforming the Consumer Cyclical Sector? (Barchart)
10:21AM	From Ashes to Glory: Is Carvana's Premium Valuation Worth It? (Zacks)
05:05AM	Why CarMax stock is rising: The evolution of the American car buying experience (USA TODAY)
Jun-24-25 01:06PM	CarMax price target raised to $81 from $80 at RBC Capital (TipRanks)
08:00AM	Auto retail sector: Portfolio manager shares his top 2 picks (Yahoo Finance Video)
Jun-23-25 04:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
09:28AM	Company News for Jun 23, 2025 (Zacks)
Jun-21-25 09:00AM	Morning Movers: GMS Inc. jumps after report of competing suitors (TipRanks)
08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
03:00AM	CarMax Inc (KMX) Q1 2026 Earnings Call Highlights: Record Retail Gross Profit and Strong Sales ... (GuruFocus.com)
Jun-20-25 06:18PM	CarMax Stock Jumps After Tariffs Boost Used-Car Demand (GuruFocus.com) +6.59%
05:31PM	S&P 500 Gains and Losses Today: Kroger Stock Soars, Accenture Shares Drop (Investopedia)
04:56PM	Analyst Report: CarMax, Inc. (Morningstar Research)
03:20PM	Stocks to Watch Friday: Kroger, TSM, Accenture, GMS (The Wall Street Journal)
03:12PM	CarMax pops on Q1 earnings: The journey to catch up to Carvana (Yahoo Finance Video)
01:59PM	Stocks to Watch Friday: TSM, Accenture, Kroger, GMS (The Wall Street Journal)
01:40PM	'Halftime' Investment Committee Stocks on the Move: CarMax, Accenture and Rocket Companies (CNBC TV)
01:25PM	CarMax Stock Rises. Used-Car Retailer Races Past Earnings Expectations. (Barrons.com)
01:03PM	Why Is CarMax (KMX) Stock Rocketing Higher Today (StockStory)
11:55AM	Top Stock Movers Now: Kroger, CarMax, Accenture, and More (Investopedia)
11:50AM	CarMax pops on strong Q1 results (CNBC TV)
11:46AM	CarMax's Q1 Sales Go Into Overdrive (Motley Fool)
11:41AM	CarMax among S&P's biggest gainers (MarketWatch)
11:19AM	CarMax Q1 Earnings Surpass Expectations, Revenues Increase Y/Y (Zacks)
10:55AM	CarMax Profit Rises as Tariff Worries Spur Used-Car Demand (The Wall Street Journal)
10:19AM	CarMax Profit Rises on Higher Revenue From Retail Used Vehicles (Investopedia)
09:30AM	CarMax (KMX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	CarMax (KMX) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:45AM	GMS shares surge on possible bidding war and other early market movers (MarketWatch)
07:35AM	Carmax Posts Higher Profit, Revenue (The Wall Street Journal)
07:31AM	CarMax shares surge on strong Q1 earnings beat (Investing.com)
07:11AM	CarMax's (NYSE:KMX) Q2 Earnings Results: Revenue In Line With Expectations, Stock Soars (StockStory)
07:09AM	CarMax stock climbs on Q1 profit and revenue beat (MarketWatch)
07:04AM	CarMax Stock Climbs. Used-Car Retailer Races Past Earnings Expectations. (Barrons.com)
06:56AM	CarMax: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports First Quarter Fiscal Year 2026 Results (Business Wire)
02:47AM	Stock Market Today: Dow, S&P 500 and Nasdaq futures flip higher after report Iran willing to discuss uranium enrichment limits (MarketWatch)
Jun-18-25 11:00PM	CarMax (KMX) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
07:00PM	TikTok, earnings, markets close for Juneteenth: What to Watch (Yahoo Finance Video)
08:31AM	5 Revealing Analyst Questions From CarMax's Q1 Earnings Call (StockStory)
Jun-16-25 09:15AM	Exploring Analyst Estimates for CarMax (KMX) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Jun-15-25 02:00PM	Fed Interest Rate Decision, Economic Data, Lennar Earnings, and What Else to Watch This Week (Barrons.com)
07:32AM	Investors eye Middle East tensions and the Fed's 'dot plot': What to know this week (Yahoo Finance)
05:00AM	What To Expect in Markets This Week: Fed Rate Decision, Juneteenth Holiday, US Retail Sales, Tesla Robotaxi Rollout (Investopedia)
05:00AM	The Fed, Juneteenth, Accenture, CarMax: What to watch in the stock market this week (Quartz)
Jun-13-25 10:00AM	CarMax (KMX) Earnings Expected to Grow: Should You Buy? (Zacks)
Jun-11-25 08:15AM	Chewy (CHWY) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Jun-09-25 09:40AM	Here's Why CarMax (KMX) is a Strong Value Stock (Zacks)
Jun-05-25 09:06AM	CarMax launches tools, resources to enhance used EV buying (TipRanks)
Jun-04-25 09:00AM	CarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying Experience (GlobeNewswire)
May-29-25 06:05PM	CarMax Announces First Quarter Conference Call and Annual Meeting Information (Business Wire)
May-27-25 10:38AM	CarMax cruises into generative AI after revamping data infrastructure (CIO Dive)
May-26-25 12:38AM	3 of Wall Street's Favorite Stocks Facing Headwinds (StockStory)
May-23-25 02:01PM	Used Car Stocks CVNA, KMX and AN Positioned for Tariff Tailwinds (TipRanks)
12:00AM	CarMax (KMX): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
May-20-25 07:50AM	Carvanas (CVNA) Remarkable U-Turn Tempered by Macro Headwinds (TipRanks)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Option Exercise	78.61	4,869	382,752	5,096	Jan 30 04:15 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Sale	84.58	4,869	411,820	227	Jan 30 04:15 PM
Tuite Tyler	Officer	Jan 28 '25	Proposed Sale	84.58	4,869	411,809		Jan 28 05:11 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Option Exercise	63.04	5,000	315,200	25,260	Jan 17 04:41 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Sale	81.43	5,000	407,150	20,260	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Option Exercise	63.04	13,009	820,087	22,457	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Sale	81.00	13,009	1,053,729	9,448	Jan 17 04:41 PM
Mayor-Mora Enrique N	Officer	Jan 15 '25	Proposed Sale	81.43	5,000	407,133		Jan 15 03:15 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Option Exercise	63.04	12,845	809,749	24,583	Jan 10 04:42 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Sale	81.94	12,845	1,052,519	11,738	Jan 10 04:42 PM
Shamim Mohammad	Officer	Jan 08 '25	Proposed Sale	81.94	12,845	1,052,472		Jan 08 04:37 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Option Exercise	63.04	57,986	3,655,437	80,789	Jan 03 04:13 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Sale	81.35	57,986	4,717,161	22,803	Jan 03 04:13 PM
Lyski James	Officer	Jan 02 '25	Proposed Sale	81.35	57,986	4,717,412		Jan 02 05:23 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Option Exercise	63.04	10,000	630,400	10,995	Dec 27 04:13 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Sale	85.30	10,000	853,000	995	Dec 27 04:13 PM
Shamim Mohammad	EVP and CITO	Dec 23 '24	Option Exercise	63.04	10,000	630,400	21,738	Dec 26 04:15 PM
Shamim Mohammad	EVP and CITO	Dec 23 '24	Sale	83.77	10,000	837,700	11,738	Dec 26 04:15 PM
Nash William D	President & CEO	Dec 23 '24	Option Exercise	63.04	120,513	7,597,140	302,196	Dec 26 04:15 PM
Nash William D	President & CEO	Dec 23 '24	Sale	83.24	120,513	10,030,953	181,683	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Option Exercise	63.04	30,245	1,906,645	31,240	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 23 '24	Option Exercise	63.04	7,600	479,104	8,595	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Sale	84.34	30,245	2,550,863	995	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 23 '24	Sale	84.00	7,600	638,400	995	Dec 26 04:15 PM
Daniels Jon G	Officer	Dec 26 '24	Proposed Sale	85.30	10,000	853,039		Dec 26 04:07 PM
Daniels Jon G	Officer	Dec 24 '24	Proposed Sale	85.00	15,000	1,275,000		Dec 26 12:22 PM
Daniels Jon G	Officer	Dec 23 '24	Proposed Sale	84.00	22,845	1,918,980		Dec 23 04:50 PM
Shamim Mohammad	Officer	Dec 23 '24	Proposed Sale	86.69	22,845	1,980,360		Dec 23 04:38 PM
Nash William D	Officer	Dec 23 '24	Proposed Sale	82.00	120,513	9,882,066		Dec 23 04:28 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience